Ian Wilkinson
University of Cambridge · Cambridge University Hospitals NHS Foundation Trust
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ian Wilkinson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:34 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06047912 · Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosteroneDr Ian B Wilkinson · unknown · Hypertension, Primary Aldosteronism, Urine Aldosterone · study chair
- N/ANCT05976438 · Skin Sodium and Salt Sensitivity of Blood PressureCambridge University Hospitals NHS Foundation Trust · unknown · Hypertension · principal investigator
- N/ANCT05856318 · Cardiometabolic Health in First Time PregnancyCambridge University Hospitals NHS Foundation Trust · recruiting · Cardiometabolic Health, Pregnancy Related, Diabetes · principal investigator
- Ph4NCT04307797 · Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 DiabetesCambridge University Hospitals NHS Foundation Trust · completed · Type 2 Diabetes, Obesity · principal investigator
- N/ANCT03835013 · Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male VolunteersCambridge University Hospitals NHS Foundation Trust · completed · Cardiovascular Diseases · principal investigator
- Ph4NCT02847338 · Comparison of Optimal Hypertension RegimensCambridge University Hospitals NHS Foundation Trust · completed · Hypertension · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 10 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:34 UTC. The ranking covers the 200 most relevant of 77 PubMed records, and a shared surname and initials can bring in a namesake. All 77 on PubMed
- Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis.J Hypertens · 1998775 citationsRCR 23.3
- Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.Circulation · 2006342 citationsRCR 8.7
- Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function.Arterioscler Thromb Vasc Biol · 2002301 citationsRCR 8.2
- Trial of Dexamethasone for Chronic Subdural Hematoma.N Engl J Med · 2020226 citationsRCR 13.6
- Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis.J Am Coll Cardiol · 2007208 citationsRCR 5.8
- Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo.Br J Clin Pharmacol · 2002188 citationsRCR 4.9
- Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.Circulation · 2012171 citationsRCR 5.4
- An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study.Hypertension · 2010169 citationsRCR 5.1
- Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor device.Hypertens Res · 2009160 citationsRCR 5.1
- Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension.Hypertension · 2009159 citationsRCR 4.7